miR-146a expression is regulated by NF-κB signaling [74] and, accordingly, changes in miR-146a expression have been described not only in CC and other cancers [68], [69], but also in psoriasis and in skin inflammatory processes [75]. This evidence concerns the gene NFKB1 and cancer.